nodes	percent_of_prediction	percent_of_DWPC	metapath
Amoxapine—CYP2D6—breast cancer	0.178	1	CbGaD
Amoxapine—HTR6—Raloxifene—breast cancer	0.124	0.396	CbGbCtD
Amoxapine—HTR2B—Raloxifene—breast cancer	0.111	0.354	CbGbCtD
Amoxapine—CYP2D6—Idarubicin—breast cancer	0.0324	0.103	CbGbCtD
Amoxapine—CYP2D6—Vinorelbine—breast cancer	0.0158	0.0505	CbGbCtD
Amoxapine—CYP2D6—Tamoxifen—breast cancer	0.0143	0.0456	CbGbCtD
Amoxapine—CYP2D6—Vinblastine—breast cancer	0.00975	0.0311	CbGbCtD
Amoxapine—CYP2D6—Doxorubicin—breast cancer	0.00599	0.0191	CbGbCtD
Amoxapine—HRH4—bone marrow—breast cancer	0.00148	0.0691	CbGeAlD
Amoxapine—ORM1—endometrium—breast cancer	0.000559	0.0261	CbGeAlD
Amoxapine—Desloratadine—CYP2D6—breast cancer	0.000515	0.117	CrCbGaD
Amoxapine—HTR2B—skin of body—breast cancer	0.000501	0.0234	CbGeAlD
Amoxapine—HRH1—nipple—breast cancer	0.0005	0.0233	CbGeAlD
Amoxapine—ADRA2A—nipple—breast cancer	0.000491	0.0229	CbGeAlD
Amoxapine—HTR2B—endometrium—breast cancer	0.000472	0.022	CbGeAlD
Amoxapine—ORM1—female reproductive system—breast cancer	0.000463	0.0216	CbGeAlD
Amoxapine—HTR7—epithelium—breast cancer	0.000451	0.021	CbGeAlD
Amoxapine—ORM1—bone marrow—breast cancer	0.000437	0.0204	CbGeAlD
Amoxapine—HTR2B—uterus—breast cancer	0.000435	0.0203	CbGeAlD
Amoxapine—ADRA1A—epithelium—breast cancer	0.000435	0.0203	CbGeAlD
Amoxapine—HTR1B—female reproductive system—breast cancer	0.000434	0.0203	CbGeAlD
Amoxapine—HTR2B—adipose tissue—breast cancer	0.000426	0.0198	CbGeAlD
Amoxapine—HTR2C—female reproductive system—breast cancer	0.000416	0.0194	CbGeAlD
Amoxapine—SLC6A4—female reproductive system—breast cancer	0.000395	0.0184	CbGeAlD
Amoxapine—CHRM1—female reproductive system—breast cancer	0.000393	0.0183	CbGeAlD
Amoxapine—ORM1—endocrine gland—breast cancer	0.000392	0.0183	CbGeAlD
Amoxapine—HTR2B—female reproductive system—breast cancer	0.000391	0.0182	CbGeAlD
Amoxapine—HTR2B—adrenal gland—breast cancer	0.000382	0.0178	CbGeAlD
Amoxapine—HTR1B—endocrine gland—breast cancer	0.000368	0.0171	CbGeAlD
Amoxapine—Desloratadine—ABCB1—breast cancer	0.000367	0.0839	CrCbGaD
Amoxapine—ADRA1A—adipose tissue—breast cancer	0.000352	0.0164	CbGeAlD
Amoxapine—SLC6A2—female reproductive system—breast cancer	0.000348	0.0162	CbGeAlD
Amoxapine—DRD2—pituitary gland—breast cancer	0.000346	0.0161	CbGeAlD
Amoxapine—HTR2A—embryo—breast cancer	0.000345	0.0161	CbGeAlD
Amoxapine—HTR1A—adrenal gland—breast cancer	0.000342	0.016	CbGeAlD
Amoxapine—SLC6A2—adrenal gland—breast cancer	0.000339	0.0158	CbGeAlD
Amoxapine—HRH1—epithelium—breast cancer	0.000337	0.0157	CbGeAlD
Amoxapine—HTR7—female reproductive system—breast cancer	0.000335	0.0156	CbGeAlD
Amoxapine—SLC6A4—endocrine gland—breast cancer	0.000334	0.0156	CbGeAlD
Amoxapine—CHRM1—endocrine gland—breast cancer	0.000333	0.0155	CbGeAlD
Amoxapine—Asenapine—CYP2D6—breast cancer	0.000332	0.0757	CrCbGaD
Amoxapine—HTR7—adrenal gland—breast cancer	0.000327	0.0152	CbGeAlD
Amoxapine—ADRA1A—adrenal gland—breast cancer	0.000315	0.0147	CbGeAlD
Amoxapine—HRH1—endometrium—breast cancer	0.000302	0.0141	CbGeAlD
Amoxapine—HTR1A—endocrine gland—breast cancer	0.000297	0.0138	CbGeAlD
Amoxapine—ADRA2A—endometrium—breast cancer	0.000297	0.0138	CbGeAlD
Amoxapine—SLC6A2—endocrine gland—breast cancer	0.000294	0.0137	CbGeAlD
Amoxapine—Asenapine—CYP3A4—breast cancer	0.000284	0.0649	CrCbGaD
Amoxapine—HTR7—endocrine gland—breast cancer	0.000283	0.0132	CbGeAlD
Amoxapine—HTR2A—epithelium—breast cancer	0.000281	0.0131	CbGeAlD
Amoxapine—ADRA1A—endocrine gland—breast cancer	0.000273	0.0128	CbGeAlD
Amoxapine—ADRA2A—uterus—breast cancer	0.000273	0.0127	CbGeAlD
Amoxapine—HRH1—adipose tissue—breast cancer	0.000272	0.0127	CbGeAlD
Amoxapine—ORM1—lymph node—breast cancer	0.000271	0.0126	CbGeAlD
Amoxapine—ADRA2A—pituitary gland—breast cancer	0.000268	0.0125	CbGeAlD
Amoxapine—DRD2—endocrine gland—breast cancer	0.000268	0.0125	CbGeAlD
Amoxapine—ADRA2A—adipose tissue—breast cancer	0.000267	0.0125	CbGeAlD
Amoxapine—HRH1—female reproductive system—breast cancer	0.00025	0.0117	CbGeAlD
Amoxapine—ADRA2A—female reproductive system—breast cancer	0.000246	0.0115	CbGeAlD
Amoxapine—HRH1—adrenal gland—breast cancer	0.000244	0.0114	CbGeAlD
Amoxapine—ADRA2A—adrenal gland—breast cancer	0.00024	0.0112	CbGeAlD
Amoxapine—Clozapine—CYP1B1—breast cancer	0.00024	0.0547	CrCbGaD
Amoxapine—HTR2B—lymph node—breast cancer	0.000229	0.0107	CbGeAlD
Amoxapine—HTR2A—pituitary gland—breast cancer	0.000228	0.0106	CbGeAlD
Amoxapine—HRH1—female gonad—breast cancer	0.000228	0.0106	CbGeAlD
Amoxapine—ADRA2A—female gonad—breast cancer	0.000224	0.0104	CbGeAlD
Amoxapine—HRH1—endocrine gland—breast cancer	0.000212	0.00987	CbGeAlD
Amoxapine—HTR2A—female reproductive system—breast cancer	0.000209	0.00974	CbGeAlD
Amoxapine—ADRA2A—endocrine gland—breast cancer	0.000208	0.0097	CbGeAlD
Amoxapine—HTR2A—adrenal gland—breast cancer	0.000204	0.00951	CbGeAlD
Amoxapine—SLC6A2—lymph node—breast cancer	0.000203	0.00948	CbGeAlD
Amoxapine—Chlordiazepoxide—CYP2D6—breast cancer	0.000197	0.045	CrCbGaD
Amoxapine—Zuclopenthixol—CYP2D6—breast cancer	0.000194	0.0442	CrCbGaD
Amoxapine—CYP2D6—female reproductive system—breast cancer	0.00019	0.00888	CbGeAlD
Amoxapine—Olanzapine—CYP2D6—breast cancer	0.000184	0.0421	CrCbGaD
Amoxapine—HTR2A—endocrine gland—breast cancer	0.000177	0.00824	CbGeAlD
Amoxapine—CYP2D6—female gonad—breast cancer	0.000173	0.00808	CbGeAlD
Amoxapine—Chlordiazepoxide—CYP3A4—breast cancer	0.000169	0.0386	CrCbGaD
Amoxapine—CYP2D6—endocrine gland—breast cancer	0.000161	0.00751	CbGeAlD
Amoxapine—Olanzapine—CYP3A4—breast cancer	0.000158	0.0361	CrCbGaD
Amoxapine—HRH1—lymph node—breast cancer	0.000146	0.00682	CbGeAlD
Amoxapine—ADRA2A—lymph node—breast cancer	0.000144	0.0067	CbGeAlD
Amoxapine—Diazepam—PTGS1—breast cancer	0.000143	0.0327	CrCbGaD
Amoxapine—Leukopenia—Capecitabine—breast cancer	0.000138	0.000463	CcSEcCtD
Amoxapine—Convulsion—Docetaxel—breast cancer	0.000138	0.000463	CcSEcCtD
Amoxapine—Paraesthesia—Paclitaxel—breast cancer	0.000138	0.000462	CcSEcCtD
Amoxapine—Olanzapine—ALB—breast cancer	0.000138	0.0315	CrCbGaD
Amoxapine—Hypertension—Docetaxel—breast cancer	0.000138	0.000461	CcSEcCtD
Amoxapine—Drowsiness—Epirubicin—breast cancer	0.000138	0.000461	CcSEcCtD
Amoxapine—Rash—Thiotepa—breast cancer	0.000138	0.00046	CcSEcCtD
Amoxapine—Dermatitis—Thiotepa—breast cancer	0.000138	0.00046	CcSEcCtD
Amoxapine—Agranulocytosis—Methotrexate—breast cancer	0.000138	0.00046	CcSEcCtD
Amoxapine—Headache—Thiotepa—breast cancer	0.000137	0.000458	CcSEcCtD
Amoxapine—Somnolence—Paclitaxel—breast cancer	0.000137	0.000457	CcSEcCtD
Amoxapine—Palpitations—Capecitabine—breast cancer	0.000137	0.000457	CcSEcCtD
Amoxapine—Loss of consciousness—Capecitabine—breast cancer	0.000136	0.000455	CcSEcCtD
Amoxapine—Nausea—Vinorelbine—breast cancer	0.000136	0.000454	CcSEcCtD
Amoxapine—Dyspepsia—Paclitaxel—breast cancer	0.000135	0.000453	CcSEcCtD
Amoxapine—Asthenia—Irinotecan—breast cancer	0.000135	0.000452	CcSEcCtD
Amoxapine—Asthenia—Mitoxantrone—breast cancer	0.000135	0.000452	CcSEcCtD
Amoxapine—Jaundice—Epirubicin—breast cancer	0.000134	0.000449	CcSEcCtD
Amoxapine—Stomatitis—Epirubicin—breast cancer	0.000134	0.000449	CcSEcCtD
Amoxapine—Decreased appetite—Paclitaxel—breast cancer	0.000134	0.000447	CcSEcCtD
Amoxapine—Hypertension—Capecitabine—breast cancer	0.000134	0.000447	CcSEcCtD
Amoxapine—Dry mouth—Docetaxel—breast cancer	0.000133	0.000445	CcSEcCtD
Amoxapine—Fatigue—Paclitaxel—breast cancer	0.000133	0.000443	CcSEcCtD
Amoxapine—Hepatitis—Methotrexate—breast cancer	0.000132	0.000442	CcSEcCtD
Amoxapine—Pollakiuria—Doxorubicin—breast cancer	0.000132	0.000442	CcSEcCtD
Amoxapine—Asthenia—Gemcitabine—breast cancer	0.000132	0.000441	CcSEcCtD
Amoxapine—Olanzapine—ABCB1—breast cancer	0.000132	0.0301	CrCbGaD
Amoxapine—Constipation—Paclitaxel—breast cancer	0.000132	0.00044	CcSEcCtD
Amoxapine—Confusional state—Docetaxel—breast cancer	0.000131	0.00044	CcSEcCtD
Amoxapine—Oedema—Docetaxel—breast cancer	0.00013	0.000436	CcSEcCtD
Amoxapine—Weight increased—Doxorubicin—breast cancer	0.00013	0.000435	CcSEcCtD
Amoxapine—Pruritus—Gemcitabine—breast cancer	0.00013	0.000435	CcSEcCtD
Amoxapine—Nausea—Thiotepa—breast cancer	0.00013	0.000434	CcSEcCtD
Amoxapine—Clozapine—CYP1A1—breast cancer	0.000129	0.0295	CrCbGaD
Amoxapine—Diarrhoea—Irinotecan—breast cancer	0.000129	0.000432	CcSEcCtD
Amoxapine—Diarrhoea—Mitoxantrone—breast cancer	0.000129	0.000432	CcSEcCtD
Amoxapine—Dry mouth—Capecitabine—breast cancer	0.000129	0.000431	CcSEcCtD
Amoxapine—Agranulocytosis—Epirubicin—breast cancer	0.000129	0.00043	CcSEcCtD
Amoxapine—Shock—Docetaxel—breast cancer	0.000128	0.000429	CcSEcCtD
Amoxapine—Pruritus—Fluorouracil—breast cancer	0.000128	0.000427	CcSEcCtD
Amoxapine—Thrombocytopenia—Docetaxel—breast cancer	0.000128	0.000427	CcSEcCtD
Amoxapine—Drowsiness—Doxorubicin—breast cancer	0.000128	0.000427	CcSEcCtD
Amoxapine—Confusional state—Capecitabine—breast cancer	0.000127	0.000426	CcSEcCtD
Amoxapine—Tachycardia—Docetaxel—breast cancer	0.000127	0.000425	CcSEcCtD
Amoxapine—Feeling abnormal—Paclitaxel—breast cancer	0.000127	0.000424	CcSEcCtD
Amoxapine—Oedema—Capecitabine—breast cancer	0.000126	0.000422	CcSEcCtD
Amoxapine—Gastrointestinal pain—Paclitaxel—breast cancer	0.000126	0.000421	CcSEcCtD
Amoxapine—Diarrhoea—Gemcitabine—breast cancer	0.000126	0.00042	CcSEcCtD
Amoxapine—Dizziness—Irinotecan—breast cancer	0.000125	0.000417	CcSEcCtD
Amoxapine—Stomatitis—Doxorubicin—breast cancer	0.000124	0.000416	CcSEcCtD
Amoxapine—Jaundice—Doxorubicin—breast cancer	0.000124	0.000416	CcSEcCtD
Amoxapine—Anorexia—Docetaxel—breast cancer	0.000124	0.000416	CcSEcCtD
Amoxapine—Shock—Capecitabine—breast cancer	0.000124	0.000415	CcSEcCtD
Amoxapine—Hepatitis—Epirubicin—breast cancer	0.000124	0.000414	CcSEcCtD
Amoxapine—Diarrhoea—Fluorouracil—breast cancer	0.000124	0.000413	CcSEcCtD
Amoxapine—Thrombocytopenia—Capecitabine—breast cancer	0.000124	0.000413	CcSEcCtD
Amoxapine—Tinnitus—Methotrexate—breast cancer	0.000123	0.000412	CcSEcCtD
Amoxapine—Tachycardia—Capecitabine—breast cancer	0.000123	0.000412	CcSEcCtD
Amoxapine—Hypoaesthesia—Epirubicin—breast cancer	0.000123	0.000412	CcSEcCtD
Amoxapine—Estazolam—CYP3A4—breast cancer	0.000123	0.028	CrCbGaD
Amoxapine—Urticaria—Paclitaxel—breast cancer	0.000122	0.000409	CcSEcCtD
Amoxapine—Hypotension—Docetaxel—breast cancer	0.000122	0.000407	CcSEcCtD
Amoxapine—Body temperature increased—Paclitaxel—breast cancer	0.000122	0.000407	CcSEcCtD
Amoxapine—Abdominal pain—Paclitaxel—breast cancer	0.000122	0.000407	CcSEcCtD
Amoxapine—Anorexia—Capecitabine—breast cancer	0.00012	0.000402	CcSEcCtD
Amoxapine—Vomiting—Irinotecan—breast cancer	0.00012	0.000401	CcSEcCtD
Amoxapine—Vomiting—Mitoxantrone—breast cancer	0.00012	0.000401	CcSEcCtD
Amoxapine—Dizziness—Fluorouracil—breast cancer	0.000119	0.000399	CcSEcCtD
Amoxapine—Agranulocytosis—Doxorubicin—breast cancer	0.000119	0.000398	CcSEcCtD
Amoxapine—Rash—Irinotecan—breast cancer	0.000119	0.000398	CcSEcCtD
Amoxapine—Rash—Mitoxantrone—breast cancer	0.000119	0.000398	CcSEcCtD
Amoxapine—Dermatitis—Irinotecan—breast cancer	0.000119	0.000397	CcSEcCtD
Amoxapine—Dermatitis—Mitoxantrone—breast cancer	0.000119	0.000397	CcSEcCtD
Amoxapine—Headache—Irinotecan—breast cancer	0.000118	0.000395	CcSEcCtD
Amoxapine—Headache—Mitoxantrone—breast cancer	0.000118	0.000395	CcSEcCtD
Amoxapine—Hypotension—Capecitabine—breast cancer	0.000118	0.000394	CcSEcCtD
Amoxapine—Insomnia—Docetaxel—breast cancer	0.000118	0.000394	CcSEcCtD
Amoxapine—Paraesthesia—Docetaxel—breast cancer	0.000117	0.000391	CcSEcCtD
Amoxapine—Alopecia—Methotrexate—breast cancer	0.000117	0.000391	CcSEcCtD
Amoxapine—Vomiting—Gemcitabine—breast cancer	0.000117	0.000391	CcSEcCtD
Amoxapine—Somnolence—Docetaxel—breast cancer	0.000116	0.000388	CcSEcCtD
Amoxapine—Rash—Gemcitabine—breast cancer	0.000116	0.000387	CcSEcCtD
Amoxapine—Dermatitis—Gemcitabine—breast cancer	0.000116	0.000387	CcSEcCtD
Amoxapine—Tinnitus—Epirubicin—breast cancer	0.000115	0.000386	CcSEcCtD
Amoxapine—Headache—Gemcitabine—breast cancer	0.000115	0.000385	CcSEcCtD
Amoxapine—Vomiting—Fluorouracil—breast cancer	0.000115	0.000384	CcSEcCtD
Amoxapine—Dyspepsia—Docetaxel—breast cancer	0.000115	0.000384	CcSEcCtD
Amoxapine—Hepatitis—Doxorubicin—breast cancer	0.000115	0.000383	CcSEcCtD
Amoxapine—Insomnia—Capecitabine—breast cancer	0.000114	0.000382	CcSEcCtD
Amoxapine—Hypoaesthesia—Doxorubicin—breast cancer	0.000114	0.000381	CcSEcCtD
Amoxapine—Rash—Fluorouracil—breast cancer	0.000114	0.000381	CcSEcCtD
Amoxapine—Dermatitis—Fluorouracil—breast cancer	0.000114	0.00038	CcSEcCtD
Amoxapine—Paraesthesia—Capecitabine—breast cancer	0.000113	0.000379	CcSEcCtD
Amoxapine—Decreased appetite—Docetaxel—breast cancer	0.000113	0.000379	CcSEcCtD
Amoxapine—Headache—Fluorouracil—breast cancer	0.000113	0.000378	CcSEcCtD
Amoxapine—Prazepam—CYP3A4—breast cancer	0.000113	0.0258	CrCbGaD
Amoxapine—Dysgeusia—Methotrexate—breast cancer	0.000113	0.000377	CcSEcCtD
Amoxapine—Fatigue—Docetaxel—breast cancer	0.000112	0.000376	CcSEcCtD
Amoxapine—Nausea—Mitoxantrone—breast cancer	0.000112	0.000375	CcSEcCtD
Amoxapine—Nausea—Irinotecan—breast cancer	0.000112	0.000375	CcSEcCtD
Amoxapine—Quetiapine—CYP2D6—breast cancer	0.000112	0.0255	CrCbGaD
Amoxapine—Constipation—Docetaxel—breast cancer	0.000112	0.000373	CcSEcCtD
Amoxapine—Dyspepsia—Capecitabine—breast cancer	0.000111	0.000372	CcSEcCtD
Amoxapine—Asthenia—Paclitaxel—breast cancer	0.00011	0.000369	CcSEcCtD
Amoxapine—Decreased appetite—Capecitabine—breast cancer	0.00011	0.000367	CcSEcCtD
Amoxapine—Alopecia—Epirubicin—breast cancer	0.000109	0.000366	CcSEcCtD
Amoxapine—Nausea—Gemcitabine—breast cancer	0.000109	0.000365	CcSEcCtD
Amoxapine—Fatigue—Capecitabine—breast cancer	0.000109	0.000364	CcSEcCtD
Amoxapine—Pruritus—Paclitaxel—breast cancer	0.000109	0.000364	CcSEcCtD
Amoxapine—Vision blurred—Methotrexate—breast cancer	0.000109	0.000363	CcSEcCtD
Amoxapine—Constipation—Capecitabine—breast cancer	0.000108	0.000361	CcSEcCtD
Amoxapine—Feeling abnormal—Docetaxel—breast cancer	0.000107	0.000359	CcSEcCtD
Amoxapine—Nausea—Fluorouracil—breast cancer	0.000107	0.000359	CcSEcCtD
Amoxapine—Tinnitus—Doxorubicin—breast cancer	0.000107	0.000357	CcSEcCtD
Amoxapine—Gastrointestinal pain—Docetaxel—breast cancer	0.000107	0.000356	CcSEcCtD
Amoxapine—Flatulence—Epirubicin—breast cancer	0.000106	0.000355	CcSEcCtD
Amoxapine—Tension—Epirubicin—breast cancer	0.000106	0.000354	CcSEcCtD
Amoxapine—Dysgeusia—Epirubicin—breast cancer	0.000106	0.000353	CcSEcCtD
Amoxapine—Diarrhoea—Paclitaxel—breast cancer	0.000105	0.000352	CcSEcCtD
Amoxapine—Nervousness—Epirubicin—breast cancer	0.000105	0.00035	CcSEcCtD
Amoxapine—Feeling abnormal—Capecitabine—breast cancer	0.000104	0.000348	CcSEcCtD
Amoxapine—Gastrointestinal pain—Capecitabine—breast cancer	0.000103	0.000345	CcSEcCtD
Amoxapine—Body temperature increased—Docetaxel—breast cancer	0.000103	0.000345	CcSEcCtD
Amoxapine—Abdominal pain—Docetaxel—breast cancer	0.000103	0.000345	CcSEcCtD
Amoxapine—Leukopenia—Methotrexate—breast cancer	0.000103	0.000345	CcSEcCtD
Amoxapine—Oxazepam—CYP3A4—breast cancer	0.000102	0.0233	CrCbGaD
Amoxapine—Dizziness—Paclitaxel—breast cancer	0.000102	0.00034	CcSEcCtD
Amoxapine—Vision blurred—Epirubicin—breast cancer	0.000102	0.00034	CcSEcCtD
Amoxapine—Alopecia—Doxorubicin—breast cancer	0.000101	0.000338	CcSEcCtD
Amoxapine—Temazepam—CYP3A4—breast cancer	0.000101	0.023	CrCbGaD
Amoxapine—Urticaria—Capecitabine—breast cancer	0.0001	0.000335	CcSEcCtD
Amoxapine—Body temperature increased—Capecitabine—breast cancer	9.98e-05	0.000334	CcSEcCtD
Amoxapine—Abdominal pain—Capecitabine—breast cancer	9.98e-05	0.000334	CcSEcCtD
Amoxapine—Convulsion—Methotrexate—breast cancer	9.98e-05	0.000334	CcSEcCtD
Amoxapine—Agitation—Epirubicin—breast cancer	9.9e-05	0.000331	CcSEcCtD
Amoxapine—Flatulence—Doxorubicin—breast cancer	9.83e-05	0.000329	CcSEcCtD
Amoxapine—Tension—Doxorubicin—breast cancer	9.79e-05	0.000327	CcSEcCtD
Amoxapine—Vomiting—Paclitaxel—breast cancer	9.78e-05	0.000327	CcSEcCtD
Amoxapine—Dysgeusia—Doxorubicin—breast cancer	9.77e-05	0.000326	CcSEcCtD
Amoxapine—Rash—Paclitaxel—breast cancer	9.7e-05	0.000324	CcSEcCtD
Amoxapine—Dermatitis—Paclitaxel—breast cancer	9.69e-05	0.000324	CcSEcCtD
Amoxapine—Nervousness—Doxorubicin—breast cancer	9.69e-05	0.000324	CcSEcCtD
Amoxapine—Syncope—Epirubicin—breast cancer	9.67e-05	0.000323	CcSEcCtD
Amoxapine—Leukopenia—Epirubicin—breast cancer	9.65e-05	0.000323	CcSEcCtD
Amoxapine—Headache—Paclitaxel—breast cancer	9.64e-05	0.000322	CcSEcCtD
Amoxapine—Clozapine—CYP2D6—breast cancer	9.63e-05	0.022	CrCbGaD
Amoxapine—Quetiapine—CYP3A4—breast cancer	9.6e-05	0.0219	CrCbGaD
Amoxapine—Palpitations—Epirubicin—breast cancer	9.52e-05	0.000318	CcSEcCtD
Amoxapine—Confusional state—Methotrexate—breast cancer	9.48e-05	0.000317	CcSEcCtD
Amoxapine—Loss of consciousness—Epirubicin—breast cancer	9.47e-05	0.000317	CcSEcCtD
Amoxapine—Vision blurred—Doxorubicin—breast cancer	9.4e-05	0.000314	CcSEcCtD
Amoxapine—Asthenia—Docetaxel—breast cancer	9.36e-05	0.000313	CcSEcCtD
Amoxapine—Convulsion—Epirubicin—breast cancer	9.34e-05	0.000312	CcSEcCtD
Amoxapine—Hypertension—Epirubicin—breast cancer	9.31e-05	0.000311	CcSEcCtD
Amoxapine—Pruritus—Docetaxel—breast cancer	9.23e-05	0.000308	CcSEcCtD
Amoxapine—Thrombocytopenia—Methotrexate—breast cancer	9.2e-05	0.000308	CcSEcCtD
Amoxapine—Agitation—Doxorubicin—breast cancer	9.16e-05	0.000306	CcSEcCtD
Amoxapine—Nausea—Paclitaxel—breast cancer	9.14e-05	0.000306	CcSEcCtD
Amoxapine—Asthenia—Capecitabine—breast cancer	9.06e-05	0.000303	CcSEcCtD
Amoxapine—Dry mouth—Epirubicin—breast cancer	8.97e-05	0.0003	CcSEcCtD
Amoxapine—Anorexia—Methotrexate—breast cancer	8.96e-05	0.0003	CcSEcCtD
Amoxapine—Syncope—Doxorubicin—breast cancer	8.94e-05	0.000299	CcSEcCtD
Amoxapine—Pruritus—Capecitabine—breast cancer	8.93e-05	0.000299	CcSEcCtD
Amoxapine—Leukopenia—Doxorubicin—breast cancer	8.93e-05	0.000298	CcSEcCtD
Amoxapine—Diarrhoea—Docetaxel—breast cancer	8.92e-05	0.000298	CcSEcCtD
Amoxapine—Confusional state—Epirubicin—breast cancer	8.87e-05	0.000296	CcSEcCtD
Amoxapine—Palpitations—Doxorubicin—breast cancer	8.81e-05	0.000295	CcSEcCtD
Amoxapine—Oedema—Epirubicin—breast cancer	8.8e-05	0.000294	CcSEcCtD
Amoxapine—Hypotension—Methotrexate—breast cancer	8.78e-05	0.000294	CcSEcCtD
Amoxapine—Loss of consciousness—Doxorubicin—breast cancer	8.76e-05	0.000293	CcSEcCtD
Amoxapine—Shock—Epirubicin—breast cancer	8.65e-05	0.000289	CcSEcCtD
Amoxapine—Convulsion—Doxorubicin—breast cancer	8.64e-05	0.000289	CcSEcCtD
Amoxapine—Diarrhoea—Capecitabine—breast cancer	8.64e-05	0.000289	CcSEcCtD
Amoxapine—Dizziness—Docetaxel—breast cancer	8.62e-05	0.000288	CcSEcCtD
Amoxapine—Thrombocytopenia—Epirubicin—breast cancer	8.61e-05	0.000288	CcSEcCtD
Amoxapine—Hypertension—Doxorubicin—breast cancer	8.61e-05	0.000288	CcSEcCtD
Amoxapine—Tachycardia—Epirubicin—breast cancer	8.58e-05	0.000287	CcSEcCtD
Amoxapine—Insomnia—Methotrexate—breast cancer	8.5e-05	0.000284	CcSEcCtD
Amoxapine—Paraesthesia—Methotrexate—breast cancer	8.44e-05	0.000282	CcSEcCtD
Amoxapine—Anorexia—Epirubicin—breast cancer	8.38e-05	0.00028	CcSEcCtD
Amoxapine—Diazepam—CYP3A4—breast cancer	8.36e-05	0.0191	CrCbGaD
Amoxapine—Somnolence—Methotrexate—breast cancer	8.36e-05	0.000279	CcSEcCtD
Amoxapine—Dizziness—Capecitabine—breast cancer	8.35e-05	0.000279	CcSEcCtD
Amoxapine—Dry mouth—Doxorubicin—breast cancer	8.3e-05	0.000278	CcSEcCtD
Amoxapine—Vomiting—Docetaxel—breast cancer	8.29e-05	0.000277	CcSEcCtD
Amoxapine—Dyspepsia—Methotrexate—breast cancer	8.27e-05	0.000277	CcSEcCtD
Amoxapine—Clozapine—CYP3A4—breast cancer	8.26e-05	0.0188	CrCbGaD
Amoxapine—Rash—Docetaxel—breast cancer	8.22e-05	0.000275	CcSEcCtD
Amoxapine—Hypotension—Epirubicin—breast cancer	8.22e-05	0.000275	CcSEcCtD
Amoxapine—Dermatitis—Docetaxel—breast cancer	8.21e-05	0.000275	CcSEcCtD
Amoxapine—Confusional state—Doxorubicin—breast cancer	8.21e-05	0.000274	CcSEcCtD
Amoxapine—Decreased appetite—Methotrexate—breast cancer	8.17e-05	0.000273	CcSEcCtD
Amoxapine—Headache—Docetaxel—breast cancer	8.17e-05	0.000273	CcSEcCtD
Amoxapine—Oedema—Doxorubicin—breast cancer	8.14e-05	0.000272	CcSEcCtD
Amoxapine—Fatigue—Methotrexate—breast cancer	8.1e-05	0.000271	CcSEcCtD
Amoxapine—Vomiting—Capecitabine—breast cancer	8.03e-05	0.000268	CcSEcCtD
Amoxapine—Shock—Doxorubicin—breast cancer	8.01e-05	0.000268	CcSEcCtD
Amoxapine—Quetiapine—ABCB1—breast cancer	7.99e-05	0.0182	CrCbGaD
Amoxapine—Thrombocytopenia—Doxorubicin—breast cancer	7.97e-05	0.000266	CcSEcCtD
Amoxapine—Rash—Capecitabine—breast cancer	7.96e-05	0.000266	CcSEcCtD
Amoxapine—Insomnia—Epirubicin—breast cancer	7.96e-05	0.000266	CcSEcCtD
Amoxapine—Dermatitis—Capecitabine—breast cancer	7.95e-05	0.000266	CcSEcCtD
Amoxapine—Tachycardia—Doxorubicin—breast cancer	7.94e-05	0.000266	CcSEcCtD
Amoxapine—Headache—Capecitabine—breast cancer	7.91e-05	0.000264	CcSEcCtD
Amoxapine—Paraesthesia—Epirubicin—breast cancer	7.9e-05	0.000264	CcSEcCtD
Amoxapine—Somnolence—Epirubicin—breast cancer	7.82e-05	0.000261	CcSEcCtD
Amoxapine—Anorexia—Doxorubicin—breast cancer	7.76e-05	0.000259	CcSEcCtD
Amoxapine—Nausea—Docetaxel—breast cancer	7.75e-05	0.000259	CcSEcCtD
Amoxapine—Feeling abnormal—Methotrexate—breast cancer	7.75e-05	0.000259	CcSEcCtD
Amoxapine—Dyspepsia—Epirubicin—breast cancer	7.74e-05	0.000259	CcSEcCtD
Amoxapine—Gastrointestinal pain—Methotrexate—breast cancer	7.69e-05	0.000257	CcSEcCtD
Amoxapine—Decreased appetite—Epirubicin—breast cancer	7.65e-05	0.000256	CcSEcCtD
Amoxapine—Hypotension—Doxorubicin—breast cancer	7.61e-05	0.000254	CcSEcCtD
Amoxapine—Fatigue—Epirubicin—breast cancer	7.58e-05	0.000254	CcSEcCtD
Amoxapine—Constipation—Epirubicin—breast cancer	7.52e-05	0.000251	CcSEcCtD
Amoxapine—Nausea—Capecitabine—breast cancer	7.5e-05	0.000251	CcSEcCtD
Amoxapine—Urticaria—Methotrexate—breast cancer	7.47e-05	0.00025	CcSEcCtD
Amoxapine—Body temperature increased—Methotrexate—breast cancer	7.43e-05	0.000248	CcSEcCtD
Amoxapine—Abdominal pain—Methotrexate—breast cancer	7.43e-05	0.000248	CcSEcCtD
Amoxapine—Insomnia—Doxorubicin—breast cancer	7.36e-05	0.000246	CcSEcCtD
Amoxapine—Paraesthesia—Doxorubicin—breast cancer	7.31e-05	0.000244	CcSEcCtD
Amoxapine—Diazepam—ALB—breast cancer	7.3e-05	0.0166	CrCbGaD
Amoxapine—Feeling abnormal—Epirubicin—breast cancer	7.25e-05	0.000242	CcSEcCtD
Amoxapine—Somnolence—Doxorubicin—breast cancer	7.24e-05	0.000242	CcSEcCtD
Amoxapine—Gastrointestinal pain—Epirubicin—breast cancer	7.19e-05	0.00024	CcSEcCtD
Amoxapine—Dyspepsia—Doxorubicin—breast cancer	7.16e-05	0.00024	CcSEcCtD
Amoxapine—Decreased appetite—Doxorubicin—breast cancer	7.07e-05	0.000237	CcSEcCtD
Amoxapine—Fatigue—Doxorubicin—breast cancer	7.02e-05	0.000235	CcSEcCtD
Amoxapine—Urticaria—Epirubicin—breast cancer	6.99e-05	0.000234	CcSEcCtD
Amoxapine—Diazepam—ABCB1—breast cancer	6.96e-05	0.0159	CrCbGaD
Amoxapine—Constipation—Doxorubicin—breast cancer	6.96e-05	0.000233	CcSEcCtD
Amoxapine—Body temperature increased—Epirubicin—breast cancer	6.95e-05	0.000232	CcSEcCtD
Amoxapine—Abdominal pain—Epirubicin—breast cancer	6.95e-05	0.000232	CcSEcCtD
Amoxapine—Clozapine—ABCB1—breast cancer	6.87e-05	0.0157	CrCbGaD
Amoxapine—Asthenia—Methotrexate—breast cancer	6.74e-05	0.000225	CcSEcCtD
Amoxapine—Feeling abnormal—Doxorubicin—breast cancer	6.71e-05	0.000224	CcSEcCtD
Amoxapine—Gastrointestinal pain—Doxorubicin—breast cancer	6.66e-05	0.000222	CcSEcCtD
Amoxapine—Pruritus—Methotrexate—breast cancer	6.65e-05	0.000222	CcSEcCtD
Amoxapine—Urticaria—Doxorubicin—breast cancer	6.47e-05	0.000216	CcSEcCtD
Amoxapine—Abdominal pain—Doxorubicin—breast cancer	6.43e-05	0.000215	CcSEcCtD
Amoxapine—Body temperature increased—Doxorubicin—breast cancer	6.43e-05	0.000215	CcSEcCtD
Amoxapine—Diarrhoea—Methotrexate—breast cancer	6.43e-05	0.000215	CcSEcCtD
Amoxapine—Asthenia—Epirubicin—breast cancer	6.31e-05	0.000211	CcSEcCtD
Amoxapine—Pruritus—Epirubicin—breast cancer	6.22e-05	0.000208	CcSEcCtD
Amoxapine—Dizziness—Methotrexate—breast cancer	6.22e-05	0.000208	CcSEcCtD
Amoxapine—Diarrhoea—Epirubicin—breast cancer	6.02e-05	0.000201	CcSEcCtD
Amoxapine—Vomiting—Methotrexate—breast cancer	5.98e-05	0.0002	CcSEcCtD
Amoxapine—Rash—Methotrexate—breast cancer	5.93e-05	0.000198	CcSEcCtD
Amoxapine—Dermatitis—Methotrexate—breast cancer	5.92e-05	0.000198	CcSEcCtD
Amoxapine—Headache—Methotrexate—breast cancer	5.89e-05	0.000197	CcSEcCtD
Amoxapine—Asthenia—Doxorubicin—breast cancer	5.84e-05	0.000195	CcSEcCtD
Amoxapine—Dizziness—Epirubicin—breast cancer	5.82e-05	0.000194	CcSEcCtD
Amoxapine—Pruritus—Doxorubicin—breast cancer	5.76e-05	0.000192	CcSEcCtD
Amoxapine—Vomiting—Epirubicin—breast cancer	5.59e-05	0.000187	CcSEcCtD
Amoxapine—Nausea—Methotrexate—breast cancer	5.58e-05	0.000187	CcSEcCtD
Amoxapine—Diarrhoea—Doxorubicin—breast cancer	5.57e-05	0.000186	CcSEcCtD
Amoxapine—Rash—Epirubicin—breast cancer	5.55e-05	0.000185	CcSEcCtD
Amoxapine—Dermatitis—Epirubicin—breast cancer	5.54e-05	0.000185	CcSEcCtD
Amoxapine—Headache—Epirubicin—breast cancer	5.51e-05	0.000184	CcSEcCtD
Amoxapine—Dizziness—Doxorubicin—breast cancer	5.38e-05	0.00018	CcSEcCtD
Amoxapine—Nausea—Epirubicin—breast cancer	5.22e-05	0.000175	CcSEcCtD
Amoxapine—Vomiting—Doxorubicin—breast cancer	5.17e-05	0.000173	CcSEcCtD
Amoxapine—Rash—Doxorubicin—breast cancer	5.13e-05	0.000172	CcSEcCtD
Amoxapine—Dermatitis—Doxorubicin—breast cancer	5.13e-05	0.000171	CcSEcCtD
Amoxapine—Headache—Doxorubicin—breast cancer	5.1e-05	0.00017	CcSEcCtD
Amoxapine—Nausea—Doxorubicin—breast cancer	4.83e-05	0.000162	CcSEcCtD
Amoxapine—HTR2A—Signaling by GPCR—HRAS—breast cancer	3.22e-06	1.75e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—MYC—breast cancer	3.21e-06	1.75e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CDKN1B—breast cancer	3.21e-06	1.75e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—PIK3CA—breast cancer	3.21e-06	1.74e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—HRAS—breast cancer	3.21e-06	1.74e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—PIK3CA—breast cancer	3.21e-06	1.74e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—TGFB1—breast cancer	3.21e-06	1.74e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—HRAS—breast cancer	3.2e-06	1.74e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—KRAS—breast cancer	3.19e-06	1.73e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—EGFR—breast cancer	3.19e-06	1.73e-05	CbGpPWpGaD
Amoxapine—DRD2—GPCR downstream signaling—AKT1—breast cancer	3.18e-06	1.73e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CXCL8—breast cancer	3.17e-06	1.72e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—PTEN—breast cancer	3.17e-06	1.72e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—PIK3CA—breast cancer	3.16e-06	1.72e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CDKN1B—breast cancer	3.16e-06	1.72e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CDKN1B—breast cancer	3.16e-06	1.71e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—MDM2—breast cancer	3.15e-06	1.71e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—HRAS—breast cancer	3.15e-06	1.71e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CASP3—breast cancer	3.15e-06	1.71e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CDKN1B—breast cancer	3.15e-06	1.71e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—IL2—breast cancer	3.15e-06	1.71e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—EGFR—breast cancer	3.14e-06	1.71e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—RAF1—breast cancer	3.14e-06	1.71e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—IL6—breast cancer	3.13e-06	1.7e-05	CbGpPWpGaD
Amoxapine—HTR2A—GPCR downstream signaling—AKT1—breast cancer	3.13e-06	1.7e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—RELA—breast cancer	3.13e-06	1.7e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—SRC—breast cancer	3.13e-06	1.7e-05	CbGpPWpGaD
Amoxapine—HRH1—GPCR downstream signaling—AKT1—breast cancer	3.12e-06	1.7e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—PIK3CA—breast cancer	3.12e-06	1.7e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PIK3CG—breast cancer	3.12e-06	1.69e-05	CbGpPWpGaD
Amoxapine—CHRM1—GPCR downstream signaling—AKT1—breast cancer	3.11e-06	1.69e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—SRC—breast cancer	3.11e-06	1.69e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—TP53—breast cancer	3.11e-06	1.69e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—ERBB2—breast cancer	3.11e-06	1.69e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—TP53—breast cancer	3.1e-06	1.69e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CASP3—breast cancer	3.1e-06	1.68e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CDKN1B—breast cancer	3.1e-06	1.68e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—IL2—breast cancer	3.1e-06	1.68e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CASP3—breast cancer	3.09e-06	1.68e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—IL2—breast cancer	3.09e-06	1.68e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CASP3—breast cancer	3.08e-06	1.67e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—IL6—breast cancer	3.08e-06	1.67e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—IL2—breast cancer	3.08e-06	1.67e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—IL6—breast cancer	3.07e-06	1.67e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—PIK3CA—breast cancer	3.07e-06	1.67e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CCND1—breast cancer	3.07e-06	1.67e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—MTOR—breast cancer	3.07e-06	1.67e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—PIK3CB—breast cancer	3.07e-06	1.67e-05	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR downstream signaling—AKT1—breast cancer	3.06e-06	1.66e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—IL6—breast cancer	3.06e-06	1.66e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—JUN—breast cancer	3.06e-06	1.66e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—VEGFA—breast cancer	3.05e-06	1.65e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CTNNB1—breast cancer	3.04e-06	1.65e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CASP3—breast cancer	3.04e-06	1.65e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—IL2—breast cancer	3.03e-06	1.65e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—VEGFA—breast cancer	3.03e-06	1.65e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—TP53—breast cancer	3.02e-06	1.64e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CCND1—breast cancer	3.02e-06	1.64e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—IL6—breast cancer	3.02e-06	1.64e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—STAT3—breast cancer	3.02e-06	1.64e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—JUN—breast cancer	3.01e-06	1.64e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CCND1—breast cancer	3.01e-06	1.64e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—KRAS—breast cancer	3.01e-06	1.63e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—JUN—breast cancer	3e-06	1.63e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CCND1—breast cancer	3e-06	1.63e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—STAT3—breast cancer	3e-06	1.63e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—JUN—breast cancer	3e-06	1.63e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CTNNB1—breast cancer	2.99e-06	1.62e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CTNNB1—breast cancer	2.98e-06	1.62e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—MMP9—breast cancer	2.98e-06	1.62e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—HRAS—breast cancer	2.97e-06	1.61e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CTNNB1—breast cancer	2.97e-06	1.61e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—TP53—breast cancer	2.97e-06	1.61e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—KRAS—breast cancer	2.97e-06	1.61e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—HRAS—breast cancer	2.97e-06	1.61e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CDKN1A—breast cancer	2.97e-06	1.61e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—PTEN—breast cancer	2.96e-06	1.61e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CCND1—breast cancer	2.95e-06	1.6e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—JUN—breast cancer	2.95e-06	1.6e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CXCL8—breast cancer	2.95e-06	1.6e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—PIK3CA—breast cancer	2.93e-06	1.59e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—MMP9—breast cancer	2.93e-06	1.59e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—HRAS—breast cancer	2.93e-06	1.59e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CTNNB1—breast cancer	2.93e-06	1.59e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—MMP9—breast cancer	2.92e-06	1.59e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CDKN1A—breast cancer	2.92e-06	1.59e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—MMP9—breast cancer	2.91e-06	1.58e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CDKN1A—breast cancer	2.91e-06	1.58e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—PTEN—breast cancer	2.91e-06	1.58e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—PTEN—breast cancer	2.91e-06	1.58e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CDKN1A—breast cancer	2.9e-06	1.58e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—PTEN—breast cancer	2.9e-06	1.57e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—MAPK8—breast cancer	2.9e-06	1.57e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—HRAS—breast cancer	2.89e-06	1.57e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—AKT1—breast cancer	2.89e-06	1.57e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—MAPK3—breast cancer	2.88e-06	1.56e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CDKN1B—breast cancer	2.88e-06	1.56e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—MMP9—breast cancer	2.87e-06	1.56e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—MAPK3—breast cancer	2.87e-06	1.56e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CDKN1A—breast cancer	2.86e-06	1.55e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—PTEN—breast cancer	2.85e-06	1.55e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—MAPK8—breast cancer	2.85e-06	1.55e-05	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—AKT1—breast cancer	2.85e-06	1.55e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—IL6—breast cancer	2.85e-06	1.54e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—MAPK8—breast cancer	2.84e-06	1.54e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—HRAS—breast cancer	2.84e-06	1.54e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—IL6—breast cancer	2.84e-06	1.54e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—AKT1—breast cancer	2.84e-06	1.54e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—TP53—breast cancer	2.84e-06	1.54e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—AKT1—breast cancer	2.84e-06	1.54e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—MAPK8—breast cancer	2.83e-06	1.54e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—AKT1—breast cancer	2.83e-06	1.53e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CASP3—breast cancer	2.82e-06	1.53e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IL2—breast cancer	2.82e-06	1.53e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—IL6—breast cancer	2.8e-06	1.52e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—MYC—breast cancer	2.8e-06	1.52e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—TGFB1—breast cancer	2.79e-06	1.52e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—MAPK8—breast cancer	2.79e-06	1.51e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—MYC—breast cancer	2.79e-06	1.51e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—AKT1—breast cancer	2.78e-06	1.51e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—TGFB1—breast cancer	2.78e-06	1.51e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—PIK3CA—breast cancer	2.77e-06	1.5e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—IL6—breast cancer	2.76e-06	1.5e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CCND1—breast cancer	2.75e-06	1.49e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—SRC—breast cancer	2.75e-06	1.49e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PIK3CD—breast cancer	2.74e-06	1.49e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—EGFR—breast cancer	2.74e-06	1.49e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—JUN—breast cancer	2.74e-06	1.49e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—PIK3CA—breast cancer	2.73e-06	1.48e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—EGFR—breast cancer	2.73e-06	1.48e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—IL6—breast cancer	2.72e-06	1.48e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CTNNB1—breast cancer	2.72e-06	1.48e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—HRAS—breast cancer	2.71e-06	1.47e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—ALB—breast cancer	2.71e-06	1.47e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—SRC—breast cancer	2.7e-06	1.47e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—SRC—breast cancer	2.7e-06	1.46e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—SRC—breast cancer	2.69e-06	1.46e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—TP53—breast cancer	2.68e-06	1.45e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—VEGFA—breast cancer	2.67e-06	1.45e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—MMP9—breast cancer	2.67e-06	1.45e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CDKN1A—breast cancer	2.66e-06	1.44e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—PTEN—breast cancer	2.65e-06	1.44e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—STAT3—breast cancer	2.65e-06	1.44e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—SRC—breast cancer	2.64e-06	1.44e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—TP53—breast cancer	2.64e-06	1.43e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—VEGFA—breast cancer	2.63e-06	1.43e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—VEGFA—breast cancer	2.63e-06	1.43e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—AKT1—breast cancer	2.62e-06	1.43e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—AKT1—breast cancer	2.62e-06	1.42e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—VEGFA—breast cancer	2.62e-06	1.42e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—STAT3—breast cancer	2.6e-06	1.41e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—STAT3—breast cancer	2.6e-06	1.41e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—IL6—breast cancer	2.6e-06	1.41e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—MAPK8—breast cancer	2.59e-06	1.41e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—STAT3—breast cancer	2.59e-06	1.41e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—NOS3—breast cancer	2.59e-06	1.41e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—KRAS—breast cancer	2.59e-06	1.41e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—AKT1—breast cancer	2.59e-06	1.4e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—VEGFA—breast cancer	2.58e-06	1.4e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—KRAS—breast cancer	2.58e-06	1.4e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—HRAS—breast cancer	2.56e-06	1.39e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—STAT3—breast cancer	2.55e-06	1.38e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—AKT1—breast cancer	2.55e-06	1.38e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—MAPK3—breast cancer	2.53e-06	1.37e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—HRAS—breast cancer	2.52e-06	1.37e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—AKT1—breast cancer	2.51e-06	1.36e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—MAPK3—breast cancer	2.49e-06	1.35e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—MAPK3—breast cancer	2.48e-06	1.35e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—MAPK3—breast cancer	2.48e-06	1.34e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—MYC—breast cancer	2.46e-06	1.34e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—SRC—breast cancer	2.46e-06	1.33e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—TGFB1—breast cancer	2.45e-06	1.33e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—IL6—breast cancer	2.45e-06	1.33e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—MAPK3—breast cancer	2.44e-06	1.32e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—MYC—breast cancer	2.42e-06	1.31e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—IL6—breast cancer	2.42e-06	1.31e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—MYC—breast cancer	2.42e-06	1.31e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—TGFB1—breast cancer	2.41e-06	1.31e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—TGFB1—breast cancer	2.41e-06	1.31e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—MYC—breast cancer	2.41e-06	1.31e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—EGFR—breast cancer	2.41e-06	1.31e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—TGFB1—breast cancer	2.4e-06	1.3e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—AKT1—breast cancer	2.4e-06	1.3e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—VEGFA—breast cancer	2.39e-06	1.3e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PIK3CB—breast cancer	2.39e-06	1.3e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—PIK3CA—breast cancer	2.38e-06	1.29e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—MYC—breast cancer	2.37e-06	1.29e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—STAT3—breast cancer	2.37e-06	1.29e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PTGS2—breast cancer	2.37e-06	1.29e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—EGFR—breast cancer	2.37e-06	1.29e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—PIK3CA—breast cancer	2.37e-06	1.28e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—TGFB1—breast cancer	2.36e-06	1.28e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—EGFR—breast cancer	2.36e-06	1.28e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—EGFR—breast cancer	2.35e-06	1.28e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—EGFR—breast cancer	2.32e-06	1.26e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—TP53—breast cancer	2.3e-06	1.25e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—TP53—breast cancer	2.29e-06	1.24e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—KRAS—breast cancer	2.27e-06	1.23e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—MAPK3—breast cancer	2.26e-06	1.23e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—AKT1—breast cancer	2.26e-06	1.23e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—KRAS—breast cancer	2.24e-06	1.21e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—PIK3CA—breast cancer	2.24e-06	1.21e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—KRAS—breast cancer	2.23e-06	1.21e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—AKT1—breast cancer	2.23e-06	1.21e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—KRAS—breast cancer	2.22e-06	1.21e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—MYC—breast cancer	2.2e-06	1.2e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—HRAS—breast cancer	2.2e-06	1.19e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—TGFB1—breast cancer	2.2e-06	1.19e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—KRAS—breast cancer	2.19e-06	1.19e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—HRAS—breast cancer	2.19e-06	1.19e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—EGFR—breast cancer	2.15e-06	1.17e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—IL6—breast cancer	2.11e-06	1.14e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—IL6—breast cancer	2.1e-06	1.14e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—PIK3CA—breast cancer	2.09e-06	1.13e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PTEN—breast cancer	2.06e-06	1.12e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—PIK3CA—breast cancer	2.05e-06	1.12e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—PIK3CA—breast cancer	2.05e-06	1.11e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—PIK3CA—breast cancer	2.04e-06	1.11e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—KRAS—breast cancer	2.03e-06	1.1e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—TP53—breast cancer	2.02e-06	1.1e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—PIK3CA—breast cancer	2.01e-06	1.09e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—TP53—breast cancer	1.99e-06	1.08e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—TP53—breast cancer	1.98e-06	1.08e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—TP53—breast cancer	1.98e-06	1.07e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—TP53—breast cancer	1.95e-06	1.06e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—AKT1—breast cancer	1.94e-06	1.06e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—AKT1—breast cancer	1.93e-06	1.05e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—HRAS—breast cancer	1.93e-06	1.05e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—HRAS—breast cancer	1.9e-06	1.03e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—HRAS—breast cancer	1.9e-06	1.03e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—HRAS—breast cancer	1.89e-06	1.03e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—PIK3CA—breast cancer	1.87e-06	1.02e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—HRAS—breast cancer	1.86e-06	1.01e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—IL6—breast cancer	1.85e-06	1e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—AKT1—breast cancer	1.83e-06	9.92e-06	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—IL6—breast cancer	1.82e-06	9.88e-06	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—IL6—breast cancer	1.82e-06	9.86e-06	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—IL6—breast cancer	1.81e-06	9.83e-06	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—TP53—breast cancer	1.81e-06	9.82e-06	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—IL6—breast cancer	1.78e-06	9.67e-06	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—HRAS—breast cancer	1.73e-06	9.39e-06	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—AKT1—breast cancer	1.71e-06	9.26e-06	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—AKT1—breast cancer	1.68e-06	9.11e-06	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—AKT1—breast cancer	1.67e-06	9.09e-06	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—AKT1—breast cancer	1.67e-06	9.07e-06	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IL6—breast cancer	1.66e-06	8.99e-06	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—AKT1—breast cancer	1.64e-06	8.92e-06	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—AKT1—breast cancer	1.53e-06	8.29e-06	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PIK3CA—breast cancer	1.46e-06	7.91e-06	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—AKT1—breast cancer	1.19e-06	6.46e-06	CbGpPWpGaD
